ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christakis, G. T.
Right arrow Articles by Rao, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christakis, G. T.
Right arrow Articles by Rao, V.

The Annals of Thoracic Surgery, Vol 58, 1040-1049, Copyright © 1994 by The Society of Thoracic Surgeons


ARTICLES

Determinants of low systemic vascular resistance during cardiopulmonary bypass

GT Christakis, SE Fremes, JP Koch, S Harwood, S Juhasz, E Sharpe, KA Deemar, C Hamilton, E Chen and V Rao
Division of Cardiovascular Surgery and Clinical Epidemiology Unit, Sunnybrook Health Science Centre, University of Toronto, Ontario, Canada.

Although low systemic vascular resistance occurs during normothermic and hypothermic cardiopulmonary bypass, the determinants of depressed systemic vascular resistance and its effect on outcomes are unknown. To assess the predictors and clinical effects of low systemic vascular resistance, 555 patients undergoing isolated coronary artery bypass grafting were evaluated prospectively. The extent of low systemic vascular resistance during bypass was estimated by the amount of the vasoconstrictor phenylephrine administered: group 1, 0 to 160 micrograms; group 2, 161 to 800 micrograms; group 3, more than 800 micrograms. Multivariate analysis identified bypass temperature, bypass time, and ventricular function as determinants of low systemic vascular resistance. Patients on normothermic bypass accounted for 65% of the patients in group 3 and only 34% of the patients in group 1 (p < 0.0001). The bypass time was longer in the patients in group 3 (97 +/- 28 minutes) than in the patients in group 1 (89 +/- 24 minutes; p < 0.006). Patients with a preoperative left ventricular ejection fraction of 0.40 or less required less phenylephrine during cardiopulmonary bypass (498 +/- 68 micrograms) than did patients with a fraction exceeding 0.40 (1,087 +/- 88 micrograms; p < 0.001). By multivariate analysis, advanced age and the presence of peripheral vascular disease were found to decrease the likelihood of low systemic vascular resistance during normothermic bypass. Diabetes, the left ventricular ejection fraction, the bypass time, and the total cardioplegia infused were found to influence the likelihood of low systemic vascular resistance during hypothermic bypass. Patients in group 3 had a higher cardiac index and lower-mean arterial pressure and systemic vascular resistance postoperatively. In those patients who received a left internal mammary artery graft, the incidences of the low-output syndrome (group 1, 4.9%; group 3, 2.7%; p = not significant) and myocardial infarction (group 1, 1.4%; group 3, 1.8%; p = not significant) were not influenced by the amount of phenylephrine infused during cardiopulmonary bypass. In those patients who were at high risk of suffering a stroke preoperatively, the hypotension induced by the low systemic vascular resistance and its treatment with phenylephrine was not associated with an increased incidence of stroke (group 1, 5.8%; group 3, 2.8%; p = not significant).


This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
M. Shahzamani, Z. Yousefi, A. N. Frootaghe, E. Jafarimehr, M. Froughi, F. Tofighi, A. N. Azadani, M. A. Pourhoseingholi, and P. N. Azadani
The Effect of Angiotensin-Converting Enzyme Inhibitor on Hemodynamic Instability in Patients Undergoing Cardiopulmonary Bypass: Results of a Dose-Comparison Study
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 185 - 191.
[Abstract] [PDF]


Home page
ICVTSHome page
J. L. Iribarren, F. M. Sagasti, J. J. Jimenez, M. Brouard, E. Salido, R. Martinez, and M. L. Mora
TNF{beta}+250 polymorphism and hyperdynamic state in cardiac surgery with extracorporeal circulation
Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1071 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Albacker, G. Carvalho, T. Schricker, and K. Lachapelle
High-Dose Insulin Therapy Attenuates Systemic Inflammatory Response in Coronary Artery Bypass Grafting Patients
Ann. Thorac. Surg., July 1, 2008; 86(1): 20 - 27.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. D. Maslow, G. Stearns, P. Batula, C. S. Schwartz, J. Gough, and A. K. Singh
The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass.
Anesth. Analg., July 1, 2006; 103(1): 2 - 8.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Langer, R. Schramm, M. Bauer, D. Tscholl, T. Kunihara, and H.-J. Schafers
Cytokine Response to Pulmonary Thromboendarterectomy
Chest, July 1, 2004; 126(1): 135 - 141.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. L. Levin, M. A. Degrange, G. F. Bruno, C. D. Del Mazo, D. J. Taborda, J. J. Griotti, and F. J. Boullon
Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery
Ann. Thorac. Surg., February 1, 2004; 77(2): 496 - 499.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. Salenger, J. S. Gammie, and T. J. Vander Salm
Postoperative Care of Cardiac Surgical Patients
Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469.
[Full Text]


Home page
PerfusionHome page
R Tosson, D Buchwald, K Klak, and A Laczkovics
The impact of normothermia on the outcome of aortic valve surgery
Perfusion, July 1, 2001; 16(4): 319 - 324.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Ohata, Y. Sawa, K. Kadoba, K. Kagisaki, K. Suzuki, and H. Matsuda
Role of nitric oxide in a temperature dependent regulation of systemic vascular resistance in cardiopulmonary bypass
Eur. J. Cardiothorac. Surg., September 1, 2000; 18(3): 342 - 347.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Koide, M. Hamawaki, T. Narishige, H. Sato, S. Nemoto, G. DeFreyte, M. R. Zile, G. Cooper IV, and B. A. Carabello
Microtubule Depolymerization Normalizes In Vivo Myocardial Contractile Function in Dogs With Pressure-Overload Left Ventricular Hypertrophy
Circulation, August 29, 2000; 102(9): 1045 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Borgdorff, G. van den Bos, and G. J. Tangelder
Extracorporeal circulation can induce hypotension by both blood-material contact and pump-induced platelet aggregation
J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 12 - 19.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Struber, J. T. Cremer, B. Gohrbandt, C. Hagl, M. Jankowski, B. Volker, H. Ruckoldt, M. Martin, and A. Haverich
Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass
Ann. Thorac. Surg., October 1, 1999; 68(4): 1330 - 1335.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Ohata, Y. Sawa, K. Kadoba, T. Masai, H. Ichikawa, and H. Matsuda
Effect of Cardiopulmonary Bypass Under Tepid Temperature on Inflammatory Reactions
Ann. Thorac. Surg., July 1, 1997; 64(1): 124 - 128.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
C. O'Dwyer, L. C. Woodson, B. P. Conroy, C. Y. Lin, D. J. Deyo, T. Uchida, and W. E. Johnston
Regional Perfusion Abnormalities With Phenylephrine During Normothermic Bypass
Ann. Thorac. Surg., March 1, 1997; 63(3): 728 - 735.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
G. T. Christakis, K. J. Buth, R. D. Weisel, V. Rao, L. Joy, S. E. Fremes, and B. S. Goldman
Randomized Study of Right Ventricular Function With Intermittent Warm or Cold Cardioplegia
Ann. Thorac. Surg., January 1, 1996; 61(1): 128 - 134.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.